ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis

Lv, Daoyuan; Jiang, Song; Zhang, Mingchao; Zhu, Xiaodong; Yang, Fan; Wang, Hui; Li, Shen; Liu, Feng; Zeng, Caihong; Qin, Weisong; Li, Limin*; Liu, Zhihong*南方医科大学; 1
Kidney Diseases2022-7DOI: 10.1159/000524164
4被引7阅读
引用收藏
分享

摘要

Introduction: Membranous nephropathy (MN) is a common chronic kidney disease in adults and a major challenge of clinical practice for its treatment. Despite major advances, since the discovery of the phospholipase A2 receptor as the major autoantigen of podocytes in MN, the mechanisms leading to glomerular damage remain elusive. Pyroptosis, a newly discovered type of programed necrotic cell death mainly mediated by gasdermin, was found to be responsible for podocyte injury in MN in our recent work. Objectives: The aim of this study was to explore the therapeutic effect of an FDA-approved drug, disulfiram (DSF), in the treatment of MN by inhibiting pyroptosis. Methods and Results: DSF significantly alleviated C3a/C5a-induced podocyte injury in vitro and renal lesions in passive Heymann nephritis (PHN) rats, as reflected by the decreased percentage of propidium iodide staining podocytes, decreased lactate dehydrogenase release from cultured podocytes and improvement in 24-h urine protein, serum albumin, serum creatinine, abnormal alterations of podocyte injury markers Desmin and WT-1 and podocyte foot process fusion in PHN rats. The protective effect of DSF on podocyte injury in vitro and in vivo can be ascribed to its inhibition of the activation and membrane translocation of the pyroptosis executor gasdermin D (GSDMD) in podocytes. DSF also inhibited the increase and activation of the pyroptosis signaling pathway NLRP3-ASC-Caspase-1/IL-18/GSDMD in C3a/C5a-treated podocytes and renal tissue of PHN rats. Conclusion: DSF is a potential drug for MN treatment, and its clinical application needs to be further investigated.

学科与关键词

关键词
Membranous nephropathyDisulfiramPyroptosisPodocyte
相关
加载中…
  • Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis
    Hu, Haoqiang; Li, Mengyuan; Chen, Binfeng; Guo, Chaohuan; Yang, Niansheng*Clinical and Experimental Nephrology, 2022, 26(11): 1055-1066.被引 4
  • Membranous nephropathy
    Ronco, Pierre*; Beck, Laurence; Debiec, Hanna; Fervenza, Fernando C.; Hou, Fan Fan; Jha, Vivekanand; Sethi, Sanjeev; Tong, Allison; Vivarelli, Marina; Wetzels, JackNature Reviews Disease Primers, 2021, 7(1): 69.被引 135
  • Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis
    Zhuang, Lili; Luo, Xiaoqing; Wu, Shufan; Lin, Zhangmei; Zhang, Yanan; Zhai, Zeqing; Yang, Fangyuan; Li, Yehao; Zhuang, Jian; Luo, Guihu; Xu, Wenchao; He, Yi*; Sun, Erwei*Cell Death Discovery, 2022, 8(1): 379.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Kidney Diseases
发表日期
2022-07
卷期
第 8 卷, 第 4 期
页码
308-318
DOI
10.1159/000524164
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China Special Project [32141004]; National Key Technology R&D Program of China [2015BAI12B02]

作者

  • L

    Lv, Daoyuan (第一作者)

    1 · southern med univ

  • J

    Jiang, Song

查看全部 12 位作者收起作者
  • Z

    Zhang, Mingchao

  • Z

    Zhu, Xiaodong

  • Y

    Yang, Fan

  • W

    Wang, Hui

  • L

    Li, Shen

  • L

    Liu, Feng

  • Z

    Zeng, Caihong

  • Q

    Qin, Weisong

  • L

    Li, Limin (通讯)

    china pharmaceut univ

  • L

    Liu, Zhihong (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417